Short answer
Alamar Biosciences Inc (ALMR) filed an 8-K current report with the SEC on September 1, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Robert Ragusa appointed Class I director effective September 1, 2026, term expiring at the 2027 Annual Meeting.
Alamar Biosciences Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Robert Ragusa appointed Class I director effective September 1, 2026, term expiring at the 2027 Annual Meeting
- Board committee assignments span Audit, Compensation, and Nominating and Corporate Governance Committees
- Appointment expands board oversight across financial reporting, executive pay, and governance matters
- Director compensation follows the company’s Non-Employee Director Compensation Policy, with standard indemnification terms
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Alamar Biosciences Inc 8-K filings
Get the next ALMR 8-K as it lands
Follow ALMR for push alerts, or ask the research agent what this filing means.